SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
54.60    -1.40 (-2.50%)
Bid:
52.60
Ask:
56.60
Spread: 4.00 (7.605%)
Market Cap: £45.60m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Trading Statement

13 Jul 2007 07:00

Flomerics Group PLC13 July 2007 Flomerics Group PLC ("Flomerics" or "the Company") Pre-Close Trading Update Flomerics Group PLC, the global supplier of specialist simulation software forelectronics and fluid flow simulation, is today providing a trading update inadvance of its interim results for the six months ended 30 June 2007. Although the first six months of the year have been challenging, the Companycontinues to make progress in integrating the Nika business, building awarenessof the Nika products in new markets and expanding its pipeline of opportunities.Through its expanded portfolio of products and additional selling capacity, theCompany is well positioned to develop its business robustly. However, asindicated in the AGM statement, building this pipeline and translating theopportunities into sales is taking longer than had been expected. This isparticularly so in the USA, where the Company has found the market weaker thanin the previous year. Flomerics continues to see a very positive reaction to the Nika product range inthose markets in which it has been introduced. It continues to build on crossselling opportunities of Nika solutions to existing Flomerics customers in theelectronics sector and is seeing benefits as a result of having broadened itsmarket beyond electronics. The directors expect the Company to report a loss in the first half of thisyear, because the costs of the investment in additional sales staff early in theyear will not be offset by increases in revenue, which are flowing through moreslowly than expected. The Company's results for the year will therefore dependeven more than usual on performance in the second half. Moreover, forecasts forthe Nika business are more difficult than for the traditional Flomericsbusiness, because it involves more sales of new products and a shorter salescycle. The Company's forecasting systems, which are well established for itstraditional business, are therefore currently showing a range of possibleoutcomes for the year. The current market expectation is at the upper end of therange and, as indicated in the AGM statement, actions are being taken to improveperformance and increase the likelihood of achieving this expectation. We willgive clearer guidance on the outlook for the year in the interim report. The Company expects to announce its interim results for the six months ended 30June 2007 in mid September 2007. Enquiries: Flomerics Group PLC:Gary Carter, Chief Executive 020 8847 3000Chris Ogle, Finance Director 020 8847 3000 Conduit PR:Christian Taylor-Wilkinson 020 7429 6666 Oriel Securities Limited (Nominated Adviser):Andrew Edwards 020 7710 7600 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Jun 20267:00 amRNSAcquisition of Helipebs Controls Ltd
28th May 20267:00 amRNS2025 Annual Report Posting & Notice of AGM
8th May 20262:28 pmRNSHolding(s) in Company
7th Apr 20267:00 amRNSAnnual Financial Report
24th Mar 20267:00 amRNSAudited Preliminary FY25 Results & Outlook update
18th Mar 20267:00 amRNSNotice of Annual results and presentation
12th Feb 20264:22 pmRNSCompletion of Acquisition
10th Feb 20264:36 pmRNSHolding(s) in Company
9th Feb 20265:25 pmRNSHolding(s) in Company
9th Feb 20264:28 pmRNSDirector/PDMR Shareholding
6th Feb 202612:08 pmRNSResult of General Meeting
22nd Jan 20264:12 pmRNSHolding(s) in Company (Correction)
22nd Jan 20262:36 pmRNSResult of Retail Offer
22nd Jan 202612:56 pmRNSHolding(s) in Company
22nd Jan 202612:48 pmRNSHolding(s) in Company
21st Jan 20262:44 pmRNSPublication of Circular
20th Jan 20263:26 pmRNSResult of Placing and Notice of General Meeting
20th Jan 20267:02 amRNSProposed Retail Offer
20th Jan 20267:01 amRNSProposed Placing And Retail Offer
20th Jan 20267:00 amRNSFull Year Trading Update & Acquisition
1st Oct 202510:39 amRNSChange of Auditor
9th Sep 20257:00 amRNSHalf-Year Report - six months ended 30 June 2025
4th Sep 20258:00 amRNSHalf-Year results - webcast presentations
29th Jul 20257:00 amRNSGroup Trading Update & Notice of Interim Results
22nd Jul 20257:00 amRNS-RNew Contract wins & Partnerships
18th Jun 20258:00 amRNS-RFlowtech wins Waterside City bridge contract
17th Jun 20252:26 pmRNSResult of AGM
27th May 20255:13 pmRNSCorrection re: timing of the 2025 AGM on 17 June
22nd May 20257:00 amRNSAvailability - FY24 Annual Report & Notice of AGM
21st May 202510:30 amRNS-RFlowtech capitalises on acquisitions opportunities
11th Apr 20257:00 amRNSDirector/PDMR Shareholding
9th Apr 20257:00 amRNSPreliminary results - year ended 31 December 2024
4th Apr 20251:19 pmRNSNotice of Results and webcast presentations
12th Feb 202511:00 amRNSDirector/PDMR Shareholding
30th Jan 20257:00 amRNSFULL YEAR TRADING UPDATE
23rd Dec 20241:53 pmRNSHolding(s) in Company
30th Sep 20247:00 amRNSPDMR - Director share dealing
26th Sep 20247:00 amRNS2024 Half-year Report & Trading update
18th Sep 20247:00 amRNSAppt of Joint Broker & Notice of Half-year results
27th Aug 20247:00 amRNSAcquisition of Thomas Wright/Thorite Group Ltd
31st Jul 20247:00 amRNSHolding(s) in Company
30th Jul 20247:00 amRNSGroup Trading Update & Notice of Interim Results
1st Jul 20247:00 amRNSChange of Adviser
19th Jun 20245:46 pmRNSHolding(s) in Company
18th Jun 20245:42 pmRNSIssue of shares to the Employees Benefit Trust
11th Jun 202412:17 pmRNSResult of AGM
31st May 202412:19 pmRNSHolding(s) in Company
22nd May 20246:03 pmRNSHolding(s) in Company
22nd May 20247:00 amRNSExercise of Warrant, Issue of new shares & TVR
20th May 20247:00 amRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.